Wells Fargo’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
14,934
+899
| +6% | +$18.4K | ﹤0.01% | 4113 |
|
|
2025
Q1 | $288K | Buy |
14,035
+1,086
| +8% | +$22.3K | ﹤0.01% | 4021 |
|
|
2024
Q4 | $293K | Buy |
12,949
+11,027
| +574% | +$250K | ﹤0.01% | 4069 |
|
|
2024
Q3 | $47.3K | Buy |
1,922
+426
| +28% | +$10.5K | ﹤0.01% | 4962 |
|
|
2024
Q2 | $34.6K | Sell |
1,496
-455
| -23% | -$10.5K | ﹤0.01% | 5056 |
|
|
2024
Q1 | $47K | Sell |
1,951
-1,908
| -49% | -$46K | ﹤0.01% | 4901 |
|
|
2023
Q4 | $88.8K | Sell |
3,859
-1,080
| -22% | -$24.9K | ﹤0.01% | 4571 |
|
|
2023
Q3 | $101K | Sell |
4,939
-5,809
| -54% | -$118K | ﹤0.01% | 4442 |
|
|
2023
Q2 | $251K | Buy |
10,748
+457
| +4% | +$10.7K | ﹤0.01% | 4211 |
|
|
2023
Q1 | $239K | Buy |
10,291
+3,272
| +47% | +$76.1K | ﹤0.01% | 4066 |
|
|
2022
Q4 | $177K | Buy |
7,019
+670
| +11% | +$16.9K | ﹤0.01% | 3966 |
|
|
2022
Q3 | $168K | Sell |
6,349
-447
| -7% | -$11.8K | ﹤0.01% | 4058 |
|
|
2022
Q2 | $196K | Sell |
6,796
-1,900
| -22% | -$54.8K | ﹤0.01% | 4049 |
|
|
2022
Q1 | $300K | Sell |
8,696
-14,029
| -62% | -$484K | ﹤0.01% | 4462 |
|
|
2021
Q4 | $996K | Buy |
+22,725
| New | +$996K | ﹤0.01% | 3852 |
|